Anticholinesterase activity of phenolic acids and their derivatives

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 68 C, Issue 3-4, 2013, Pages 125-132

  Szwajgier, Dominik ^a  

^a UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Butyrylcholinesterase; Phenolic acid

Indexed keywords

EID: 84878783533     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2013-3-408     Document Type: Article

References (37)

1. Alvarez A., Opazo C., Alarcon R., Garrdio J., and Inestrosa N. (1997), Acetylcholinesterase promotes the aggregation of amyloid β-protein fragments by forming a complex with the growing fibrils. J. Mol. Biol. 272, 348-361.
2. Bourne L. C. and Rice-Evans C. (1998), Bioavailability of ferulic acid. Biochem. Biophys. Res. Commun. 253, 222-227.
3. Campos E. O., Alvarez A., and Inestrosa N. C. (1998), Brain acetylcholinesterase promotes amyloid-β-peptide aggregation but does not hydrolyze amyloid precursor protein peptides. Neurochem. Res. 23, 135-140.
4. Cheng C. Y., Su S. Y., Tang N. Y., Ho T. Y., Chiang S. Y., and Hsieh C. L. (2008), Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting of ICAM-1 mRNA expression in rats. Brain Res. 13, 136-150.
5. Cho J. Y., Kim H. S., Kim D. H., Yan J. J., Suh H. W., and Song D. K. (2005), Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of betaamyloid peptide (1-42) in mice. Prog. Neuropsy-chopharmacol. Biol. Psychiatry 29, 901-907.
6. Couteau D., McCartney A. L., Gibson G. R., Williamson G., and Faulds C. B. (2001), Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid. J. Appl. Microbiol. 90, 873-881.
7. Ellman G. L., Lourtney D. K., Andres V., and Gmelin G. (1961), A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
8. Giacobini E. (2004), Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol. Res. 50, 433-440.
9. Hamaguchi T., Ono K., Murase A., and Yamada M. (2009), Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-β aggregation pathway. Am. J. Pathol. 175, 2557-2565.
10. Hermann H. (1992), Contents of principle plant phenols in fruits. Fluess. Obst 59, 66-70.
11. Herrmann K. (1989), Occurrence and content of hydroxycinnamic and hydroxybenzoic acid compounds in foods. Crit. Rev. Food Sci. Nutr. 28, 315-347.
12. Howes M.-J. R., Perry N. S. L., and Houghton P. J. (2003), Plants with traditional uses and activities relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother. Res. 17, 1-18.
13. Hsieh M. T., Tsai F. H., Lin Y. C., Wang W. H., and Wu C. R. (2002), Effects of ferulic acid on the impairment of inhibitory avoidance performance in rats. Planta Med. 68, 754-756.
14. 2+/H2O2: Insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders. Neurochem. Int. 48, 318-327.
15. Karakida F., Ikeya Y., Tsunakawa M., Yamaguchi T., Ikarashi Y., Takeda S., and Aburada M. (2007), Cerebral protective and cognition-improving effects of sinapic acid in rodents. Biol. Pharm. Bull. 30, 514-519.
16. Karczmar A. Q. (1998), Anticholinesterases: dramatic aspect of their use and misuse. Neurochem. Int. 32, 401-411.
17. Kim H. S., Cho J. Y., Kim D. H., Yan J. J., Lee H. K., Suh H. W., and Song D. K. (2004), Inhibitory effects of long-term administration of ferulic acid on microgial activation induced by intracerebroventricular injecttion of beta-amyloid peptide (1-42) in mice. Biol. Pharm. Bull. 27, 120-121.
18. Kim M. J., Choi S. J., Lim S.-T., Kim H. K., Heo H. J., Kim E.-K., Jun W.-J., Cho H. Y., Kim Y. J., and Shin D. H. (2007), Ferulic acid supplementation prevents trimethyltin-induced cognitive deficits in mice. Biosci. Biotechnol. Biochem. 71, 1063-1068.
19. Mamiya T., Kise M., and Morikawa K. (2008), Ferulic acid attenuated cognitive deficits and increase in carbonyl proteins induced by buthionine-sulfoximine in mice. Neurosci. Lett. 430, 115-118.
20. Miyazawa M., Watanabe H., and Kameoka H. (1997), Inhibition of acetylcholinesterase activity by monoterpenoids with a p-menthane skeleton. J. Agric. Food Chem. 45, 677-679.
21. Orhan I., Kartal M., Tosun F., and Sener B. (2007), Screening of various phenolic acids and flavonoid derivatives for their anticholinesterase potential. Z. Naturforsch. 62c, 829-832.
22. Perry N. S. L., Houghton P. J., Theobald A., Jenner P., and Perry E. K. (2000), In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. J. Pharm. Pharmacol. 52, 895-902.
23. Perry N. S. L., Houghton P. J., Sampson J., Theobald A. E., Hart S., Lis-Balchin M., Hoult J. R. S., Evans P., Jenner P., Milligan S., and Perry E. K. (2001), In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. J. Pharm. Pharmacol. 53, 1347-1356.
24. Rao A. A., Sridhar G. R., and Das U. N. (2007), Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease. Med. Hypotheses 69, 1272-1276.
25. Rhee I. K., van Rijn R. M., and Verpoorte R. (2003), Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography. Phytochem. Anal. 14, 127-131.
26. Sabbagh M. N., Farlow M. R., Relkin N., and Beach T. G. (2006), Do cholinergic therapies have disease-modifying effects in Alzheimer's disease? Alzheimer's Dementia 2, 118-125.
27. Savelev S., Okello E., Perry N. S. L., Wilkins R. M., and Perry E. K. (2003), Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil. Pharmacol. Biochem. Behav. 75, 661-668.
28. Scalbert A. and Williamson G. (2000), Dietary intake and bioavailability of polyphenols. J. Nutr. 130, 2073S-2085S.
29. Seloke D. J. and Schenk D. (2003), Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 43, 544-584.
30. Shahwar D., Rehman S. U., and Raza M. A. (2010), Acetyl cholinesterase inhibition potential and antioxidant activities of ferulic acid isolated from Impatiens bicolor Linn. J. Med. Plants Res. 4, 260-266.
31. Szwajgier D. and Borowiec K. (2012a), Phenolic acids from malt are efficient acetylcholinesterase and butyrylcholinesterase inhibitors. J. Inst. Brew. 118, 40-48.
32. Szwajgier D. and Borowiec K. (2012b), Screening for cholinesterase inhibitors in selected fruits and vegetables. EJPAU 15, available online: http://www.ejpau.media.pl/volume15/issue2/abs-06.html
33. Wang H., Zhou G., Gao X., Wang Y., and Yao W. (2007), Acetylcholinesterase inhibitory-active components of Rhodiola rosea L. Food Chem. 105, 24-27.
34. Whitehouse P. J., Price D. L., Clark A. W., Coyle J. T., and DeLong M. R. (1981), Alzheimer's disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10, 115-126.
35. Yabe T., Hirahara H., Harada N., Ito N., Nagai T., Sanagi T., and Yamada H. (2010), Ferulic acid induces neural progenitor cell proliferation in vitro and in vivo. Neuroscience 165, 515-524.
36. Yan J.-J., Cho J.-Y., Kim H.-S., Kim K.-L., Jung J.-S., Huh S.-O., Suh H.-W., Kim Y.-H., and Song D.-K. (2001), Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol. 133, 89-96.
37. Yu L., Zhang Y., Ma L., Fang J., and Yu T. (2006), Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain. Eur. Neuropsychopharmacol. 16, 170-177.